MAEL Augments Cancer Stemness Properties and Resistance to Sorafenib in Hepatocellular Carcinoma through the PTGS2/AKT/STAT3 Axis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MAEL Augments Cancer Stemness Properties and Resistance to Sorafenib in Hepatocellular Carcinoma through the PTGS2/AKT/STAT3 Axis
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 12, Pages 2880
Publisher
MDPI AG
Online
2022-06-11
DOI
10.3390/cancers14122880
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
- (2021) Terence Kin-Wah Lee et al. Nature Reviews Gastroenterology & Hepatology
- Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
- (2021) Dima Hattab et al. Pharmaceutics
- JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles
- (2021) Jaime A Castro-Mondragon et al. NUCLEIC ACIDS RESEARCH
- Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer
- (2020) Yu-Xin Jiang et al. BRITISH JOURNAL OF CANCER
- Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential
- (2020) Yu-Man Tsui et al. BRITISH JOURNAL OF CANCER
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment
- (2018) Xiao-Feng Dong et al. CLINICAL CANCER RESEARCH
- Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
- (2018) Hongping Zheng et al. HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma
- (2018) Tom Tan-To Cheung et al. Liver Cancer
- Maelstrom Directs Myeloid-Derived Suppressor Cells to Promote Esophageal Squamous Cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway
- (2018) Pupu Li et al. Cancer Immunology Research
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- IL-8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF-κB pathway in prostate cancer
- (2017) Yidi Guo et al. Molecular Medicine Reports
- TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions
- (2017) Heonjong Han et al. NUCLEIC ACIDS RESEARCH
- MAEL expression links epithelial-mesenchymal transition and stem cell properties in colorectal cancer
- (2016) Qingguo Li et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B
- (2016) X-D Li et al. ONCOGENE
- Mael is essential for cancer cell survival and tumorigenesis through protection of genetic integrity
- (2016) Su-Hyeon Kim et al. Oncotarget
- Functional and structural insights into the piRNA factor Maelstrom
- (2015) Kaoru Sato et al. FEBS LETTERS
- Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology
- (2015) Tetsuhiro Chiba et al. HEPATOLOGY RESEARCH
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
- (2014) Antonina V. Kurtova et al. NATURE
- Label-retaining liver cancer cells are relatively resistant to sorafenib
- (2013) Hong-Wu Xin et al. GUT
- Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling
- (2013) Lulu Liu et al. HEPATOLOGY
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
- (2011) Terence Kin Wah Lee et al. Cell Stem Cell
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- CD13 is a therapeutic target in human liver cancer stem cells
- (2010) Naotsugu Haraguchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt
- (2009) Dong Bai et al. INTERNATIONAL JOURNAL OF CANCER
- Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
- (2008) Xi Chen et al. CELL
- Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells
- (2008) David J. Wong et al. Cell Stem Cell
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
- Deregulation of a STAT3-Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness
- (2008) N. de la Iglesia et al. JOURNAL OF NEUROSCIENCE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stat3 and c-Myc Genome-Wide Promoter Occupancy in Embryonic Stem Cells
- (2008) Benjamin L. Kidder et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search